Prospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Artif Intell Gastroenterol. Oct 28, 2022; 3(4): 105-116
Published online Oct 28, 2022. doi: 10.35712/aig.v3.i4.105
Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease
Yumi Kusano, Kei Funada, Mayumi Yamaguchi, Miwa Sugawara, Masaya Tamano
Yumi Kusano, Kei Funada, Mayumi Yamaguchi, Masaya Tamano, Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Koshigaya 343-8555, Saitama, Japan
Miwa Sugawara, Nutrition Unit, Dokkyo Medical University Saitama Medical Center, Koshigaya 343-8555, Saitama, Japan
Author contributions: Kusano Y reviewed the literature and contributed to manuscript drafting; Funada K analyzed and interpreted the imaging findings; Yamaguchi M drafted the tables and figures; Sugawara M conducted dietary counseling for patients; Tamano M revised the manuscript for important intellectual content; all authors issued final approval for the version to be submitted.
Institutional review board statement: Approval was obtained from the Biomedical Ethics Committee of the authors’ affiliated hospital (No. 2014).
Clinical trial registration statement: The clinical trial is registered with clinical research support office of the authors' affiliated hospital. Details can be found at
Informed consent statement: Written informed consent was obtained from all patients for publication of this report and any accompanying images.
Conflict-of-interest statement: None of the authors have any commercial or financial involvements in connection with this study that represent or appear to represent any conflicts of interest.
Data sharing statement: Participants gave informed consent for data sharing.
CONSORT 2010 statement: The authors have read the CONSORT Statement—checklist of items, and the manuscript was prepared and revised according to the CONSORT Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: Masaya Tamano, PhD, Professor, Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya 343-8555, Saitama, Japan.
Received: June 22, 2022
Peer-review started: June 22, 2022
First decision: July 11, 2022
Revised: July 13, 2022
Accepted: October 26, 2022
Article in press: October 26, 2022
Published online: October 28, 2022
Core Tip

Core Tip: Use of artificial intelligence (AI)-based nutrition management software (Calomeal) appeared to raise awareness of nonalcoholic fatty liver disease patients’ dietary habits, and they showed significant decreases in liver enzyme and triglyceride levels at the 6-mo follow-up compared to baseline. The food analysis capability of the AI package used in this study was 75.1%, and patient satisfaction with the AI-based dietary counselling was high. However, due to the limitations of the food analysis capabilities of AI, it did not directly alleviate the burden of registered dietitians, and improvements in the analytical capabilities of AI are much anticipated.